INR 76.42
(2.36%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 975.81 Million INR | 13.64% |
2022 | 858.65 Million INR | -0.11% |
2021 | 859.57 Million INR | 24.36% |
2020 | 691.22 Million INR | 37.3% |
2019 | 503.44 Million INR | -21.07% |
2018 | 637.85 Million INR | -6.88% |
2017 | 684.98 Million INR | 4.63% |
2016 | 654.66 Million INR | 10.35% |
2015 | 593.25 Million INR | -15.9% |
2014 | 705.45 Million INR | -1.29% |
2013 | 714.66 Million INR | -1.45% |
2012 | 725.18 Million INR | 31.91% |
2011 | 549.74 Million INR | 16.92% |
2010 | 470.2 Million INR | 18.79% |
2009 | 395.81 Million INR | 10.72% |
2008 | 357.5 Million INR | 28.62% |
2007 | 277.94 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 FY | 975.81 Million INR | 13.64% |
2023 Q4 | 975.81 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 831.88 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 858.65 Million INR | -0.11% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 858.65 Million INR | 0.0% |
2022 Q2 | 755.69 Million INR | 0.0% |
2021 Q4 | 859.57 Million INR | 0.0% |
2021 FY | 859.57 Million INR | 24.36% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 717.93 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 Q4 | 691.22 Million INR | 0.0% |
2020 FY | 691.22 Million INR | 37.3% |
2020 Q2 | 473.22 Million INR | 0.0% |
2019 Q4 | 503.44 Million INR | 0.0% |
2019 FY | 503.44 Million INR | -21.07% |
2019 Q2 | 584.57 Million INR | 0.0% |
2018 FY | 637.85 Million INR | -6.88% |
2018 Q4 | 637.85 Million INR | 0.0% |
2018 Q2 | 574.03 Million INR | 0.0% |
2017 Q2 | 582.15 Million INR | 0.0% |
2017 FY | 684.98 Million INR | 4.63% |
2017 Q4 | 684.98 Million INR | 0.0% |
2016 Q4 | 654.66 Million INR | 0.0% |
2016 FY | 654.66 Million INR | 10.35% |
2016 Q2 | 525.75 Million INR | 0.0% |
2015 Q4 | 593.25 Million INR | 0.0% |
2015 FY | 593.25 Million INR | -15.9% |
2015 Q2 | 576.02 Million INR | 0.0% |
2014 Q2 | 700.04 Million INR | 0.0% |
2014 Q4 | 705.45 Million INR | 0.0% |
2014 FY | 705.45 Million INR | -1.29% |
2013 Q4 | 714.66 Million INR | 0.0% |
2013 FY | 714.66 Million INR | -1.45% |
2013 Q2 | 787.98 Million INR | 0.0% |
2012 Q4 | 725.18 Million INR | 0.0% |
2012 FY | 725.18 Million INR | 31.91% |
2011 Q4 | 549.74 Million INR | 0.0% |
2011 FY | 549.74 Million INR | 16.92% |
2010 FY | 470.2 Million INR | 18.79% |
2009 FY | 395.81 Million INR | 10.72% |
2008 FY | 357.5 Million INR | 28.62% |
2007 FY | 277.94 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 101.347% |
NATCO Pharma Limited | -5.81 Billion INR | 116.775% |
Suven Pharmaceuticals Limited | 144.97 Million INR | -573.085% |
Syncom Formulations (India) Limited | 46.21 Million INR | -2011.642% |
Achyut Healthcare Limited | -3.74 Million INR | 26149.413% |
Ajanta Pharma Limited | -954.9 Million INR | 202.19% |
Alkem Laboratories Limited | -1.6 Billion INR | 160.632% |
Alpa Laboratories Limited | 35.36 Million INR | -2659.412% |
Alembic Pharmaceuticals Limited | 3.86 Billion INR | 74.759% |
AstraZeneca Pharma India Limited | -5.01 Billion INR | 119.468% |
Aurobindo Pharma Limited | 3.69 Billion INR | 73.579% |
Bajaj HealthCare Limited | 3.29 Billion INR | 70.421% |
Bliss GVS Pharma Limited | -1.15 Billion INR | 184.285% |
Brooks Laboratories Limited | 49.48 Million INR | -1871.933% |
Divi's Laboratories Limited | -39.77 Billion INR | 102.454% |
Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 92.443% |
Eris Lifesciences Limited | 13.8 Billion INR | 92.932% |
FDC Limited | -57.75 Million INR | 1789.658% |
Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 122.771% |
Glenmark Life Sciences Limited | -2.84 Billion INR | 134.327% |
Granules India Limited | 9.28 Billion INR | 89.492% |
Gufic Biosciences Limited | 3.19 Billion INR | 69.452% |
Hester Biosciences Limited | 2.29 Billion INR | 57.402% |
Indoco Remedies Limited | 6.47 Billion INR | 84.933% |
Ind-Swift Laboratories Limited | -4.15 Billion INR | 123.496% |
Ipca Laboratories Limited | 11.41 Billion INR | 91.452% |
Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 170.206% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 49.516% |
Lasa Supergenerics Limited | 205.79 Million INR | -374.157% |
Laurus Labs Limited | 24.38 Billion INR | 95.998% |
Lupin Limited | 17.19 Billion INR | 94.324% |
Mankind Pharma Limited | -9.9 Billion INR | 109.849% |
Medicamen Biotech Limited | 160.31 Million INR | -508.68% |
Medico Remedies Limited | 78.67 Million INR | -1140.275% |
Megasoft Limited | 1.28 Billion INR | 24.094% |
Piramal Pharma Limited | 42.27 Billion INR | 97.692% |
RPG Life Sciences Limited | -364.7 Million INR | 367.565% |
Sigachi Industries Limited | 859.94 Million INR | -13.473% |
Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 203.611% |
Unichem Laboratories Limited | 931.91 Million INR | -4.71% |
Wanbury Limited | 1.1 Billion INR | 11.761% |
Windlas Biotech Limited | -273.04 Million INR | 457.388% |
ZIM Laboratories Limited | 983.6 Million INR | 0.792% |
Zydus Lifesciences Limited | 3.91 Billion INR | 75.056% |
Procter & Gamble Health Limited | -2.34 Billion INR | 141.559% |
Amrutanjan Health Care Limited | -248.79 Million INR | 492.22% |
Bal Pharma Limited | 1.26 Billion INR | 22.773% |
Strides Pharma Science Limited | 23.25 Billion INR | 95.804% |
Venus Remedies Limited | -267.7 Million INR | 464.517% |
Aarti Pharmalabs Limited | 2.61 Billion INR | 62.64% |
Nectar Lifesciences Limited | 6.15 Billion INR | 84.152% |
Shilpa Medicare Limited | 9.06 Billion INR | 89.241% |
Aarti Drugs Limited | 5.54 Billion INR | 82.413% |
IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 188.605% |
Suven Life Sciences Limited | -1.63 Billion INR | 159.767% |
Ind-Swift Limited | 9.5 Billion INR | 89.738% |
Valiant Laboratories Limited | -295.03 Million INR | 430.748% |
J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 65.411% |
Solara Active Pharma Sciences Limited | 10.02 Billion INR | 90.27% |
Themis Medicare Limited | 764.96 Million INR | -27.563% |
Hikal Limited | 7.96 Billion INR | 87.752% |
Torrent Pharmaceuticals Limited | 31.83 Billion INR | 96.934% |
Sequent Scientific Limited | 4.17 Billion INR | 76.648% |
Novartis India Limited | -5.89 Billion INR | 116.564% |
Wockhardt Limited | 18.27 Billion INR | 94.659% |
Jubilant Pharmova Limited | 27.07 Billion INR | 96.395% |
Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 5390.095% |
Neuland Laboratories Limited | -214.05 Million INR | 555.863% |
Morepen Laboratories Limited | -231.17 Million INR | 522.111% |
Kilitch Drugs (India) Limited | 120.03 Million INR | -712.912% |